| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |